Product Liability Archive » June, 2008

Product Liability - June, 2008

116 articles

• Canada Court Refuses To Toss Wyeth Premarin Case
• Jones Day Adds Litigation Partner From Kirkland
• Medical Device Act Would Restore State Remedies
• Bill Would Bar Felons From Seeking FDA's OK
• High Court Rejects $20.7M Pollution Award Appeal
• ICT Loses Summary Judgment Bid In Sealer Case
• BP Blast Victims Ask High Court To Stay Plea Deal
• Foam Company Settles Club Fire Claims
• Body Parts Mastermind Sentenced To 18-54 Years
• European Regulators Warn Of Anemia Drug Risks
• Tyson Resolves Dispute Over Antibiotic-Free Claims
• MTBE Judge Backpedals On Expert Testimony Ruling
• Anheuser-Busch To Eliminate Caffeinated Malt Drinks
• Exxon Ruling Will Drill Punitive Awards: Experts
• Studio Sues DreamWorks Over Toxic Chemical Claim
• Judge Approves Settlement In Eating Disorder Case
• Shoreline Settles Suit Over Tour Boat Disaster
• Bike Maker Sanctioned In Product Liability Suit
• High Court Cuts $2B From Exxon Valdez Damages
• Day Of Reckoning Arrives For Scruggs
• Seroquel Plaintiffs Must Turn Over Zyprexa Info
• Water Conservationists Sue EPA Over Transfer Rule
• Superfund Parties May Get 'Voluntary' Cleanup Costs
• Total May Be Liable For Cleanup Costs: EU Court
• Firm Fights For Fee Payout In Medtronic MDL
• FDA Panel To Review Safety Of Contrast Agent
• Judge Closes Merck Derivative Suit Over Vioxx
• Hospital In W.R. Grace Case Appeals Class Bid Ruling
• Justice Dept.'s Paxil Investigation Gets Wider
• Pfizer Ignored Neurontin Suicide Link: Testimony
• Carbon Nanotubes: Canary In The Mine?
• Class Action Against GM Allowed To Proceed
• City Says Exxon Shirked Petroleum Cleanup Duties
• FDA Committee OKs Psoriasis Drug For Kids
• Settling Injury Claims Early Is Best Bet: Study
• FDA Broadens Unsafe OTC Drug List
• Suppliers Sued In Duke Hospital Contamination
• No Summary Judgment For Exxon In MTBE Case
• 2nd Circuit To Restaurants: Post Calorie Data Or Pay
• U.S., China Applaud Progress On Food Safety Plan
• W.R. Grace Judge Rebuffs ZAI Claimants
• FDA Warns Companies That Sell Fake Cancer Cures
• Medtronic Judge OKs Protocol For Attorneys' Fees
• N.Y. Court Moves Out-Of-State Plaintiff's Lipitor Case
• Benzene Cancer Cases Can Shift Venue: Texas Court
• BIPI Withheld Mirapex Study: Plaintiffs' Lawyer
• Dana Agrees To Allow $125M Claim To End EPA Spat
• Appeals Court Tosses Suit Over Ford Door Handles
• FDA Exacts Tougher Labels For Anti-Psychotic Drugs
• High Court Asks SG For Opinion On Asbestos Case
• Child's Family Wins $13.5M In Sizzler E. Coli Suit
• Tyson Sues USDA Over Chicken Labels
• Epstein Becker Partner Joins Thompson Hine
• Court Shoots Down 12th Congoleum Ch. 11 Plan
• J&J Psoriasis Drug Might Pose Risk: FDA Staff
• Hernia Plaintiff Asks For Sanctions After Mediation
• Stryker Faces Yet Another Suit Over Pain Pump
• Sen. Grassley Calls For FDA Probe Of Paxil
• Asarco Parent Makes $4.1B Asset Bid
• Medical Monitoring: Gone With The '90s?
• Kia Sephia Class Wrongly Certified: Fla. Court
• New Evidence Rule 502: How Much Help Will It Be?
• FDA Needs To Update Food Safety Plan, GAO Says
• EPA's Risk Assessment Changes 'Orwellian': NRDC
• Judge Nixes Exxon Bid For Info On $423M MTBE Deal
• N.Y. AG To Sue Drugstore Chains Over Old Goods
• Calif. City Drops 'Threatened Well' Claims In MTBE Suit
• Lawyer Demands Warnings On Herbalife Products
• EPA Gives Recalled Lawn Products Clean Bill
• 'Natural' Products Contained Known Toxin: Calif. AG
• White House Increases Funding Request For FDA
• Class Action Accuses Restaurant Chains Of Hiding Fat
• Victims Look To Take Up BP Case With Supreme Court
• Judge OKs Comair Plaintiffs' Bid For Punitive Cash
• Metabolife CEO Gets 6 Months For Misleading FDA
• Wyeth Calls For Ousting Of Lawyers In Prempro MDL
• Ethex Recalls Certain Morphine Tablets
• Vioxx Rulings Could Bode Ill For N.J. Class Actions
• Bad Brakes To Cost Kia $6M: Jury
• Heparin-Related Deaths Continue To Climb
• Texas Law Limits Makers' Duty To Defend: 5th Circ.
• $79M Philip Morris Verdict Heads Back To High Court
• Life Sciences Cos. Face More Shareholder Suits
• Mississippi AG Labeled A 'Scruggs Confederate'
• FDA Sets Up Panel To Review Bisphenol A Research
• California Jury Breaks Taser's Winning Streak
• J&J's Regranex Ups Cancer Mortality Risk: FDA
• Now Is The Time To Re-Examine Compliance Programs
• Wyeth Gets Federal Backing In Preemption Case
• Firm Takes Aim At Fen-Phen Client For Defamation
• Merck Must Turn Over Docs In Fosamax MDL: Judge
• FDA Ponders Changes To Lens Solution Regulations
• FDA Settles Lawsuit Over Mercury In Dental Fillings
• DOJ Targets Honeywell Over Zylon Bulletproof Vests
• Air France Insurers Go To Court Over 2005 Crash
• Oil Cos. To Shell Out $1.7M To Kids In MTBE Suit
• FDA Probes Drugs' Link To Cancer In Children
• Class Decertified In St. Croix Refinery Case
• Aredia Plaintiffs Say Cancer Doctor Must Testify
• Off-Label Marketing On Shaky Ground
• N.J. High Court Reinstates Dismissal Of Vioxx Suit
• FDA Links Suicide And Epilepsy Drugs
• Judge Endorses W.R. Grace's $291M Truce
• Guidant Plaintiffs Attorneys May Not Withdraw: Judge
• Tyson Yanks Antibiotic-Free Chicken Claim
• Dalkon Shield Plaintiff's Malpractice Claims Remanded
• AT&T Settles Class Claims Over Mobile Content
• Judge Sticks Dow, Rockwell With $926M In Damages
• Anti-Obesity Drug Linked To 5 Deaths In U.K.
• Bayer's Trasylol Increases Risk Of Death: Study
• 5th Circuit Revives Suits Over Civilian Deaths In Iraq
• Abbott Recalls Low-Calcium Baby Formula
• Fox Rothschild Expands S.F. Litigation Team
• TransUnion Eyes End To Decade-Long Class Action
• Studies, Senator Prompt FDA To Look At Chantix
• Lilly Moves Zyprexa Suit To Federal Court